Fernando Albericio is Research Professor at the University of KwaZulu-Natal (South Africa), Full Professor at the University of Barcelona (Spain), and Visiting Professor at the King Saud University (Saud Arabia). 

Fernando Albericio holds a Ph.D. in Chemistry from the University of Barcelona (1980). Following postdoctoral work (1981-1984) at Tufts University, the Université d’Aix-Marseille, and the University of Minnesota, he was appointed Associate Professor at the University of Barcelona. After a few years, he took up the position of Director of Peptide Research at Milligen-Biosearch, Boston, USA (1992-1994), and then re-joined the University of Barcelona in 1995, when he was promoted to Full Professor. He also served as Executive Director of the Barcelona Science Park (2005-2011).

His major research interests cover practically all methodological aspects of peptide synthesis, as well as synthesis of peptides and small molecules with therapeutic activities, mainly in the field of cancer and infectious diseases. His group also is being involved in the development of new strategies for drug delivery. He has published over 900 scientific paper and co-authored four books. He has filled more than 55 patents. He is Editor in Chief of several scientific journal and acting in the Editorial Board of several others. He has been honored with a Doctorate Honoris Causa by the Universidad de Buenos Aires (Argentina), the Leonidas Zervas award by the European Peptide Society, the Vincent du Vigneaud award by the American Peptide Society, among others. During the last years, part of his efforts has been focused to make the peptide synthesis greener and better.

https://www.nrf.ac.za/content/2020-professor-fernando-albericio

In 2010 Chris completed his PhD at The Northern Institute for Cancer Research, Newcastle University, on the development of novel inhibitors of protein kinases. He then undertook a postdoctoral appointment in a collaboration between Syngenta and Durham University from 2010-2012, in which he developed novel herbicide syngergists to combat multiple herbicide resistant weeds in wheat crops. After this, in 2012 he competed a second postdoc position at Durham University in peptide chemistry, working with Steven Cobb on peptoids and fluoroaromatics, before being appointed as a temporary lecturer in 2013-14.

He has since held academic positions Liverpool John Moores University, and was an Associate Professor in synthetic chemistry and a Bicentennial Research Leader in the School of Engineering and Physical Sciences at Heriot-Watt University. In 2021 Chris moved to the EaStChem School of Chemistry at University of Edinburgh as Senior Lecturer in Medicinal Chemistry, where his research focusses on fluorine and peptides in drug discovery and as tools for biology. Specifically, his team are interested in tackling neurological and neurodegenerative diseases. In addition to his academic role, Chris is a Director and co-founder of the peptide synthesis spin-out company PepMoTec Ltd.

https://coxonresearchgroup.wordpress.com/dr-chris-coxon/

Dr Ishwar Singh is a Reader in Antimicrobial Drug Discovery and Development and Medicinal Chemistry at the Departments of Pharmacology & Therapeutics and Chemistry, University of Liverpool. He leads many ground-breaking research programmes focused on AMR. He has made notable seminal contributions to AMR such as the first highly efficient synthesis and provision of simplified teixobactin analogues (a new class of antibiotics). He led a significant breakthrough in simplified design and an efficient synthesis of highly potent teixobactin analogues and their application in first successful treatment of mice against resistant bacterial infections.

https://www.liverpool.ac.uk/translational-medicine/staff/ishwar-singh/

Louis YP Luk is a Lecturer at the School of Chemistry of Cardiff University. He obtained his BSc in Chemistry and Microbiology & Immunology at the University of British Columbia. He obtained his PhD at the same university under the supervisor of Martin E Tanner, followed by post-doctoral studies in the laboratories of Stephen BH Kent at the University of Chicago and Rudolf K Allemann at Cardiff University. Louis became a University Research Fellow in 2015 and was recently tenured at Cardiff University. Combining his training in enzymology and peptide chemistry together, Louis’ current research focuses on artificial enzyme design, miniprotein synthesis and protein bioconjugation chemistry.

https://louisluklab.org/

I got my PhD in Industrial Chemistry at the University of Milan in 2008 and, after a brief experience as a consultant, in 2009 I moved to Aberdeen to contribute to the set-up of an organic/medicinal chemistry lab at the Institute of Medical Sciences. Here I worked on several projects spacing from medicinal chemistry to radiochemistry and more recently peptide chemistry. 

In 2012 I was awarded a Postdoctoral and Early Career Researcher Exchange Fund by SINAPSE for a 9 months visit at Prof. Tobias Ritter Laboratory, Harvard University.  In 2019 I became an independent Research Fellow at the Institute of Medical Sciences, Aberdeen.

Over the years I gained experience in the synthesis of small molecules, peptidomimetics and peptides as well in the preparation of clinical grade PET tracers (mainly Fluorine-18 based such as ([18F]FDG, [18F]NaF, [18F]FMISO, [18F]FAZA, [18F]FLT,) and in the development of novel radiotracers.

My research is focused on (1) the preparation of new radiotracers for PET imaging and in the repurpose of already developed tracer as imaging tool for new diseases and on (2) the design and synthesis of peptides and peptidomimetic useful as drugs for the treatment of different diseases.

I am always happy to embark on new fields explorations. 

Dr. Brunello Nardone was awarded a Ph.D. in Organic Chemistry (2014) from the University of Salerno (Italy). He spent the last year of his PhD at the IRB Institute (Barcelona) under the supervision of Prof Fernando Albericio to work on peptide synthesis and native chemical ligation.

After a postdoctoral experience at the University of St Andrews and University of Oxford in the group of Prof Jim Naismith, he joined NPL as peptide chemist in the Biometrology group.

In 2019 he has joined CEM Corporation as Life Science sales technical specialist.

Dr. Christian Behn earned a Ph.D. in Chemistry (1989) from the University of Aachen (Germany).

After his postdoctoral training at the Roche Institute for Molecular Biology, Nutley NJ, USA, he joined Abimed Analysen-Technik, Germany. He developed the world's first automated SPOT synthesizer together with the inventor Dr. Ronald Frank and others in 1994.

In 2002 he joined INTAVIS Bioanalytical Instruments. He served as an application manager for solid-phase peptide synthesis until 2020. Since May 1st, 2020 he is supporting the application and sales of peptide syntheses systems at CEM corporation.

Giorgio Marini studied organic chemistry and pharmaceutical technologies at the University of Milan where he got is degree in 1997.

After a few years working as a clinical monitor for an american Clinical Research Organization, he joined the field of scientific instrumentation, working for several international companies like Buchi Italy, Buchi Labortechnik AG and Biotage Corporation as a sales representative and product manager. 

In 2004 he has joined CEM Corporation as a Life science technical specialist, contributing to the promotion of Microwave Solid Phase Peptide Synthesis all over Europe and around the world.